Qiagen N.V. (QGEN)
Healthcare • Diagnostics & Research
StockNYSENetherlandsNL0015002SN0
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Qiagen N.V., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 14 Nov 2026 10:40. Information, not advice. Showing the last 90 days. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 03 Feb 2027 16:00 | 0.59 | — | — | Upcoming |
| 03 Nov 2026 19:00 | 0.63 | 0.65 | +3.6% | Beat |
| 04 Aug 2026 20:00 | 0.60 | 0.62 | +3.5% | Beat |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Older results and the annual figures: create a free account to see them
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 13 Nov 2026 | 50.09 | 50.14 | 49.83 | 49.89 | -0.42% | 1,642,100 | |
| 12 Nov 2026 | 50.30 | 50.31 | 50.01 | 50.10 | -0.40% | 4,241,000 | |
| 11 Nov 2026 | 50.30 | 50.40 | 50.26 | 50.30 | -0.42% | 2,372,300 | |
| 10 Nov 2026 | 50.47 | 50.55 | 50.20 | 50.51 | -0.08% | 5,322,600 | |
| 09 Nov 2026 | 50.57 | 50.65 | 50.51 | 50.55 | +0.44% | 5,388,400 | |
| 1,255 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Cell Lysis / Cell Fractionation - Global Strategic Business Report 2026: Capture the $4.5 Billion Market by 2032 | Features Competitive Intelligence on Thermo Fisher, Beckman Coulter, Bio-Rad, Qiagen and Merck (opens in a new tab) 12 Nov 2026 15:00
- RNA Interference (RNAi) - Global Strategic Business Report: Capture the US$8 Billion 2032 Market as Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Qiagen, Benitec BioPharma, and Silence Therapeutics (opens in a new tab) 12 Nov 2026 14:06
- Transfection Technologies - Global Strategic Business Report 2026: Capitalize on a $2.5 Billion Market by 2032 as Thermo Fisher, Lonza, Bio-Rad, Qiagen and MilliporeSigma Accelerate (opens in a new tab) 11 Nov 2026 14:21
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 50.10 USD
- Market cap
- 10.3B
- Dividend yield
- 0.70%
- Payout ratio
- 19%
- Last dividend
- 0.3500 USD · 07 Jul 2026
- Exchange
- NYSE
- Country
- Netherlands
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 07 Jul 2026 | 0.3500 USD |
| 02 Jul 2025 | 0.2500 USD |
| 4 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow QGEN and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.